Elanco Animal Health Inc
corporate_fare Company Profile
Elanco Animal Health Inc (NYSE:ELAN) is a publicly traded company in the Life Sciences sector. Wiseek has independently scored 21 items for ELAN at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-11-19, rated 7/10. Across its 20 most recent items scored 7 or higher, the top rating is 8/10, with 9 rated 8 or above. Recent SEC coverage for ELAN spans 10-Q, 8-K, DEF 14A, 10-K.
Recent high-impact activity:
- Elanco Authorizes $600M Share Buyback Near 52-Week High
- Elanco Beats Q3 Estimates, Raises 2026 Guidance on Pet Health Strength
- Elanco 10-Q Details Q3 Profit Swing: $18M Net Income, 56.9% Gross Margin, Debt Cut to $3.45B
- Elanco Beats Q3, Raises Full-Year Guidance and Hits 2.9x Leverage Milestone
- Elanco Guides FY Revenue to $5.16B-$5.18B
Financial Snapshot
Short Interest & Short Volume
7.18 days to coverFINRA reported short interest of 32,923,699 shares in ELAN as of the October 30, 2026 settlement, a 5.8% increase from the prior period — about 7.2 days to cover at its recent average daily volume. On November 20, 2026, 44.1% of ELAN volume reported to FINRA trade-reporting facilities was marked short.
Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.